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Abstract
Taxol is perhaps the most successful drug used for the treatment of various cancers. Comprehensive literature
accumulated on therapeutics of the drug has indicated numerous side effects. In this paper, by use of fluorescence
 . 7 y1spectroscopy, it is shown that taxol binds to DNA with an affinity constant K of 1.08=10 M . This binding isa
 .accompanied by a large ‘red edge excitation shift’ REES of fluorescence emission maximum in taxol–DNA complex. The
results point to an interaction of taxol with its core eight-membered ring in the DNA groove and the three phenyl rings
projecting away from the DNA. The drug encompasses about two base pairs of DNA upon binding to it. Systematic studies
with taxol analogues confirms such a mode of binding. These interesting findings on hitherto unknown taxol–DNA
interactions may have clinical implications in view of its large number of side effects and pharmacokinetics. q 1998
Elsevier Science B.V. All rights reserved.
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1. Introduction
Taxol isolated from the Western yew, Taxus bre˝i-
w xfolia 1 , has emerged as the most promising antineo-
plastic drug for treatment of colon, ovarian, lung and
w xbreast cancer as well as melanoma and lymphoma 2 .
Its detailed structure–activity relationship have been
w xworked out 3 and the intense interest in taxol is a
consequence of the demonstration by Horwitz et al.
w x4 , that it affects the tubulin–microtubule equilib-
rium. It decreases the critical concentration and the
induction time required for polymerization of tubulin
to microtubules. Taxol’s inhibitory activity of micro-
) Corresponding author. Fax: q91-0212-335153; E-mail:
kng@ems.ncl.res.in
1 Also corresponding author.
tubule depolymerisation arrests cell proliferation at
w xthe interjunction of G2 and prophase 5 .
Taxol also affects various other cellular processes,
e.g., increased synthesis of tumor necrosis factor
 . w xTNFa 6 , and inhibition of DNA synthesis initia-
w xtion by thrombin and epidermal growth factor 7,8 . It
is also shown to be associated with disturbances in
many other cellular processes that lack direct relation
with cell division. It affects transport of several pro-
teins viz., insulin, catecholamine, prothrombinase and
w xcollagenase across plasma membrane 8,9 and in-
hibits phosphatase activity on Bcl-2 protein in fine
tuning of the signal transduction pathway and pro-
w xgrammed cell death 10 . In mice, taxol is known to
accumulate in the plasma and the tissues upon intra-
w xperitoneal administration 11 . Therapeutic interest in
taxol as a drug has led to exhaustive research that has
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pointed out a battery of side effects. The effect of
introducing taxol during radiation treatment of cancer
has been shown to result in concentration dependent
w xincreased death of cells 12 .
At a molecular level conformation of taxol is
highly solvent sensitive and exhibits the phenomena
of ‘hydrophobic collapse’ in various organic solvents
w x13 . It is suggested that it binds to tubulin with
primary recognition of the taxane ring followed by
w xadditional interaction with the side chains 13,14 . A
recent study has shown incorporation of taxol into
hydrophobic region of model membranes resulting in
conformational changes of both the C13 side chain
w xand the main taxane ring 15 . In vitro studies have
shown that taxol drastically reduces the effect of
externally added DNA, which inhibits the assembly
of microtubules from solutions of tubulin isolated
w xfrom pig brain 16 . In view of the above observa-
tions, the direct interaction of taxol with DNA has
important relevance especially since the drug is al-
ready released for human chemotherapy.
This paper presents results which shows that taxol
has favourable molecular interaction with DNA. The
binding of taxol with DNA is accompanied by a large
 .‘red edge excitation shift’ REES of its fluorescence
emission maximum in taxol–DNA complex. This
together with CD properties suggests that taxol binds
to DNA through the taxane ring system, very much
w xsimilar to its interaction with tubulin 14 . In the
bound form taxol inhibits DNA dependent DNA syn-
thesis.
2. Materials and methods
All chemicals used were of the highest purity
available and were used without further purification.
Unless otherwise mentioned all spectral measure-
ments were performed in 10 mM Tris buffer pH
.7.2 , containing 100 mM NaCl and 20 mM MgCl .2
Taxol and its analogues were a kind gift from the
National Cancer Institute, USA. A stock solution of
taxol prepared in 0.1% acetic acid in methanol was
diluted with the buffer just before use.
Ethidium bromide displacement assay was per-
w xformed as reported in literature 17 . Typically, DNA
 .20 mM was added incrementally to 1 mM aqueous
ethidium bromide solution, until the rise in ethidium
 .bromide fluorescence l s475 nm, l s610 nmex em
attained saturation. To this complex, small aliquots 2
.  .ml of concentrated taxol solutions 820 mM were
added till the drop in intensity reached a constant
value. C value is the concentration of the drug50
which caused a 50% drop in the fluorescence inten-
sity in EtBr–DNA complex.
Fluorescence spectra were recorded on Perkin
Elmer LS 50B luminescence spectrometer. The emis-
sion spectra of taxol was obtained in the range 260 to
400 nm upon excitation at 230 nm, using a slit width
of 5 nm each and a scan speed of 100 nmrmin. The
excitation spectra were recorded from 200 to 500 nm,
with the excitation and emission slit widths of 10 and
5 nm, respectively. Fluorescence titration experi-
ments were performed by keeping the taxol concen-
tration constant and stoichiometrically varying the
DNA concentration. The titration data was fitted into
 .the Stern–Volmer Eq. 1 :
I rIs1qK DNA 1 .0 SV
where I and I are the fluorescence intensities of the0
probe in the absence and presence of DNA. K isSV
the Stern–Volmer quenching constant which is a
measure of the efficiency of fluorescence quenching
by DNA.
The binding affinities of taxol to DNA was calcu-
lated from the fluorescence titration curves. By using
the fluorescence data, concentration of free probe was
 .determined using Eq. 2 , where C is the totalT
concentration of the added probe, C is:F
C sC IrI yP r 1yP 2 .  .  .F T 0
the concentration of the free probe and I and I are0
the fluorescence intensities in the presence and in the
absence of DNA, respectively. P is the ratio of
observed fluorescence quantum yield of the probe in
bound form to that in free form. The value of P was
w xobtained from a plot of IrI vs. 1r DNA such that0
the limiting fluorescence yield is given by the y-in-
 .tercept. The amount of bound probe C at anyB
concentration is equal to C yC .T F
Scatchard analysis was done according to the mod-
w xified equation of McGhee and von Hippel 18 using
w xa plot of rrC vs. r, where r is equal to C r DNA .F B
ny1
rrC sK 1ynr 1ynr r 1y ny1 r .  .  .F i
3 .
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 .In Eq. 3 , K is the intrinsic binding constant and ni
is the binding size in base pairs. These values can be
obtained from the linear regression best fit of the
data.
Scheme 1.
The binding stoichiometry of the polynucleotide–
drug complex was estimated from the intersection of
the straight lines in a plot of normalized increase in
fluorescence against the molar ratio of polynucleotide
to ligand. The intersection point gives the number of
bound nucleotides per drug molecule.
All CD spectra were recorded on a JASCO J600
machine. Conformation of DNA bound taxol was
obtained by subtracting the CD signal of only DNA
from that of the complex. This would in effect give
the CD signal of taxol bound to DNA. The oligo-
 . wnucleotide d CGCGAATTCGCG Dickerson’s do-2
xdecamer used for taxol complexation studies was
synthesized on a Pharmacia ‘Gene Assembler Plus’
w xusing standard phosphoramadite chemistry 19 puri-
fied by FPLC and the purity rechecked by HPLC.
Although all the results presented in this paper use
Dickerson’s dodecamer, interaction of taxol with
 .lDNA Boehringer Mannheim gave similar results.
Primer extension reactions were carried out with
pGEM-3Z plasmid as the template and Sp6 primer
 .both purchased from Promega, Madison, USA . The
 .  .template 1 mg and the primer 10 pmol were
 .annealed in 10 mM Tris pH 7.2 , 20 mM MgCl and2
50 mM NaCl by heating at 658C for 5 min followed
by slow cooling to room temperature. Primer exten-
sion reaction was carried with dNTP mixture contain-
ing gy32P dCTP and 1 unit Klenow enzyme
 .DNA-PolI fragment . In another set of reaction, the
annealed sample was incubated with taxol 8 to 64
.nM, respectively for 15 min before primer extension
reaction. The reaction was terminated by the addition
 .of 20 mM EDTA. The samples were then run on a
1% agarose gel. After the run, the gel was dried and
 .exposed to X-ray film, at y708C Scheme 1 .
3. Results
Fig. 1 shows the fluorescence spectrum of taxol in
aqueous solutions, with excitation at 230 nm and
emission maximum in the range of 330–340 nm, and
the effect of DNA addition on the spectrum. The
 .fluorescence of taxol arises from i the C13 side
chain containing two phenyl groups, one in the main
 .chain and the other linked by an amide bond, and ii
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a phenyl ring at C2 position on the eight-membered
w x wtaxane ring 15 . Other analogues of taxol viz., 10-
deacetyl taxol, Baccatin III, 10-deacetyl baccatin III
 .xand cephalomanine Scheme 1 used in present study
have fluorescence properties very much similar to
taxol. This set of analogues have one, two or all the
three phenyl systems and the structural basis of bind-
ing of taxol and its analogues to DNA can be system-
atically monitored by fluorescence spectra arising
from these segments.
The fluorescent spectra of taxol alone was found to
be highly dependent on the solvent polarity, with a
change from methanol to acetonitrile resulting in a
blue shift of about 30 nm in the emission maximum
 . w xl 15 . This behaviour was attributed to aem,max
‘hydrophobic collapse’ of taxol structure in going
from relatively nonpolar acetonitrile to polar
methanol. Fig. 2 shows the concentration dependent
changes in the fluorescence signature of taxol in
aqueous Tris buffer. The emission l exhibits amax
blue shift of 20 nm upon increasing taxol concentra-
tion from 0.04 to 102 nM, with a simultaneous rise in
the fluorescence intensity that attains saturation be-
yond ;51 nM concentration. This behaviour sug-
gests an aggregation of taxol with a Critical Aggrega-
 .tion Constant of 6.4 nM Fig. 2, spectra 4 .
Fig. 1. Effect of DNA on the fluorescence spectra of taxol 3.2
.  .  .  .  .nM . DNA concentrations: 1 none, 2 1.9 mM, 3 3.2 mM, 4
 .6.3 mM, 5 6.7 mM. For other conditions, see Section 2.
Fig. 2. Fluorescence spectra of taxol in 10 mM Tris buffer, as a
 .  .  .function of concentration 1 0.04 nM, 2 0.4 nM, 3 1.6 nM,
 .  .  .  .  .4 3.2 nM, 5 6.4 nM, 6 25.6 nM, 7 51.2 nM, and 8 102.4
nM.
3.1. Fluorescence studies of taxol–DNA binding
Fig. 1 shows the effect of stoichiometric addition
 .of synthetic oligonucleotide d CGCGAATTCGCG 2
on fluorescence spectra of taxol, at room temperature.
It is seen that increasing the concentration of the
oligonucleotide results in a gradual decrease in fluo-
rescence intensity of taxol upto a maximum of ca.
50%, without effecting any perceptible shifts in fluo-
rescence l . A similar fluorescence quenchingmax,em
behaviour was observed for 10-deacetyl taxol, 10-
deacetyl baccatin, baccatin-III and cephalomanine that
have different number of phenyl rings, upon interac-
tion with DNA.
 y1.The Stern–Volmer quenching constants Kq
computed from the fluorescence changes of taxol and
its analogues upon interaction with DNA was in the
range of 0.2 to 0.35 mMy1 of DNA, with only a very
small variation among the different taxol analogues
 .Table 1 . 10-Deacetyl taxol required highest amount
of DNA to achieve a 50% quenching of the initial
fluorescence as indicated by the Ky1 values. Theq
quenching of taxol fluorescence by added cesium
chloride showed no difference among the free and
DNA-bound form. An analysis of the binding affinity
of taxol to DNA by Scatchard plot showed a marked
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Table 1
Stern–Volmer quenching constants
y1 y1Compound K mmol KSV q
 .Dickerson’s 12 mer
Taxol 0.35 2.8
10-deacetyl–Taxol 0.2 5
Bacattin III 0.27 3.6
10-deacetyl–Bacattin 0.35 2.8
Cephalomanine 0.25 4
 .deviation from linearity. An affinity constant K ofa
1.08=107 My1 was obtained for taxol–DNA bind-
ing from a linear double reciprocal plot.
A knowledge of the binding stoichiometry of the
drug–DNA complex would be helpful in characteriz-
ing the geometry of the drug binding to DNA. This
was computed from Fig. 3 by the intersection point
on the binding isotherms, giving a binding site size of
slightly less than two nucleotides per bound drug
molecule.
The displacement of DNA intercalated ethidium
bromide by groove binding molecules has been used
Fig. 3. Fluorescence binding isotherms for the association of
 .taxol with DNA in 10 mM TRIS buffer pH 7.2 , containing 50
mM NaCl and 20 mM MgCl . The binding stoichiometry in2
terms of number of nucleotide basesrdrug molecule is the value
at the intersection of the two straight lines.
Fig. 4. The displacement of ethidium bound to DNA by addition
of taxol as followed by fluorescence of ethidium bromide, Ex.
475 nm, Em. 610 nm. The final drug concentration is indicated
on x-axis.
as a standard technique to assay DNA binding agents
w x20 . The binding constants of drugs to DNA can be
estimated by measuring the loss of ethidium fluores-
cence as a function of added ligand. In such a
competitive binding assay, taxol displaced ethidium
bromide bound to DNA leading to a drop in fluores-
cence of ethidium bromide by 50% corresponding to
a C value of 4.6 mM, thereby supporting a strong50
complexation affinity with DNA as found from Fig.
4.
3.2. REES
In order to provide further evidence for taxol–DNA
binding, a study of the restriction in mobility of taxol
upon binding to DNA was attempted. For a fluo-
rophore in bulk nonviscous solvent, the dipolar relax-
ation of the solvent molecules around the fluorophore
in the excited state is much faster than the fluores-
cence life time. However in highly viscous solvents,
where the dipolar relaxation of the solvent molecules
in the excited state is much slower, the decay rates
and the wavelength of maximum emission show de-
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Fig. 5. The effect of excitation wavelength change on the emis-
 .  .sion wavelength of taxol 3.2 nM in the absence - - - - and
 .presence of DNA . Other conditions as in Section 2.
w xpendence on the excitation wavelength 21–23 . Such
a shift in the wavelength of maximum emission
called REES, is a good indicator of not only the
fluorophore environment but also constrained mobil-
ity resulting from its binding to another molecule.
Fig. 5 shows the REES exhibited by taxol in both
the free form and upon binding to DNA. While free
taxol exhibited a REES of about 12 nm in aqueous
media, saturation with DNA increased the REES
value significantly to 40 nm. This not only confirms
the strong binding of taxol to DNA, but also suggests
a large restriction in its mobility as a consequence of
its binding to DNA.
3.3. CD studies
Taxol exhibits two prominent CD bands: a nega-
tive band at 298 nm and a sharp positive band at 232
w xnm 15 . The interaction of taxol with DNA elicited
 .considerable changes in its CD spectra Fig. 6 . The
232 nm band of taxol upon binding to DNA shifted
 .towards shorter wavelengths 5 nm with a positive
increase in intensity. While no changes occurred in
the position of the broad negative band at 285–295
nm, a large increase in the positive intensity was
observed upon DNA binding.
w x  .Fig. 6. CD spectra of taxol 3.2 nM alone solid line and when
 .bound to DNA 8 mM . Spectra were recorded in 10 mM TRIS
 .buffer pH 7.2 , containing 50 mM NaCl and 20 mM MgCl .2
3.4. Inhibition of DNA synthesis by taxol
In the present study, we attempted DNA-PolI
 .Klenow fragment driven extension of SP6 primer
Fig. 7. Histogram showing the extent of primer extended prod-
 .  .  .ucts in the absence C and in presence of taxol, 1 64 nM; 2
 .  .32 nM; 3 16 nM and 4 8 nM. Inset: Autoradiogram showing
 .the extended products by Klenow enzyme in absence C or
 .presence of taxol 1–4 .
( )A.G. Krishna et al.rBiochimica et Biophysica Acta 1381 1998 104–112110
using pGEM-3Z plasmid as the template. It was
observed that taxol inhibits DNA synthesis in a con-
 .centration dependent manner Fig. 7 . A total inhibi-
tion of DNA synthesis was observed in presence of
0.064 mM taxol. As low a concentration as 2 nM
taxol was sufficient to significantly inhibit DNA syn-
thesis. The inhibition of DNA synthesis due to the
binding of taxol to the Klenow fragment of DNA-PolI
was ruled out by use of enzyme preincubated with
taxol for 30 min and removal of free taxol by passing
the mixture through a G-10 column. Such preincu-
bated enzyme had no effect on DNA synthesis activ-
ity, suggesting that taxol may inhibit DNA synthesis
 .by binding to the DNA as a substrate and not to the
enzyme.
4. Discussion
A useful attribute of ethidium binding to DNA is
that its fluorescence is enhanced about 50-fold, mak-
ing it a convenient probe to measure DNA binding of
w xother drugs 20 . The addition of a DNA binding
agent induces a progressive decrease in fluorescence
of ethidium due to its displacement from the duplex.
This also allows distinguishing non-intercalative
binding agents from intercalating agents: agents hav-
 .ing a large site size groove binders require corre-
spondingly smaller concentrations to saturate the sites.
As shown in Fig. 4, taxol displaces intercalated ethid-
ium leading to a 50% drop in intensity at a concentra-
tion of 4.6 mM, indicating a fairly high binding
 6 y1.constant in the range of 10 M with non-interca-
lation as a probable mode of binding.
The fluorescence of taxol arises from the three
aromatic rings. The titration of taxol with DNA
causes no significant change in the position of the
 .l of taxol Fig. 1 suggesting that taxol bindingem, max
to DNA does not change the average local environ-
 .ment of these three phenyl rings Table 2 . An inter-
calation or a direct groove binding of the phenyl
rings attached to C13 and C2 side chains would be
expected to elicit strong changes in their fluorescence
w xspectral properties 24 . Thus the binding of taxol
with DNA presumably occurs through the core
eight-membered taxane ring of taxol rather than by
involvement of the phenyl rings. In taxol all three
phenyl rings are oriented on the same side of the
Table 2
Emission properties of Taxol
% Dioxane l l Stokes shiftex, max em, max
100 216.7 286.3 112,183
90 216.7 286.3 112,183
80 216.1 286.6 116,246
60 215.5 285.7 114,020
50 215.5 285.7 113,774
40 215 285.7 114,019
30 214.9 286.3 116,049
20 213.8 286 118,076
10 212.1 284.4 119,858
5 210.3 284.9 124,511
0 213.8 326.5 161,448
TaxolqDNA 220 345 164,690
eight-membered ring system, allowing a facile bind-
ing of taxane ring from the opposite side. The rela-
tively different orientation of the ring 3 with respect
to the other rings does not affect taxol’s interaction
with DNA. In this mode of taxane binding, the three
phenyl rings are projected away from DNA into bulk
water, without significant role for them in DNA
recognition. The absence of one or many phenyl rings
in taxol analogues, baccatin and cephalomanine,
therefore has no effect per se on DNA binding. This
type of binding also places the 10-acetyl group to-
wards the DNA and may assist in its recognition
since 10-deacetyl taxol showed a weaker DNA bind-
ing compared to taxol. Coincidentally, this is similar
to the proposed binding of taxol to tubulin, mediated
w xby the taxane ring 14 .
Since the aromatic rings, which are the fluores-
cence reporting groups on taxol, are not involved in
DNA binding, it is difficult at this juncture to pin
 .point the groove preference majorrminor for the
drug to bind DNA. The recognition of macrocyclic
rings to DNA has precedence in the binding of
w xantitumor antibiotic anthramycin 25 . Its seven-mem-
bered core ring is known to fit snugly into the minor
groove of the DNA. CsCl mediated fluorescence
quenching constants for taxol, either free or in DNA
bound form are same, supporting the proposed mode
of binding, in which the ring systems would be easily
accessible to the quencher in bulk water.
The fluorescence intensity of taxol decreases upon
binding to DNA in a manner, qualitatively similar to
 .the effect of dilution Fig. 2 , suggesting that taxol
binds to DNA as a monomer rather than in aggre-
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gated form. The concentration of taxol used for DNA
binding studies was 3.2 nM, much less than its CAgC
 . w x6.4 nM 26 . DNA binding of taxol leads to the
break up of even these low number aggregates, con-
sequently leading to a drop in the fluorescence inten-
sity. Earlier studies reported on the effect of taxol on
the microtubule assembly have indicated tubulin
polymerization with taxol concentration as low as 50
w xnM 5 . In comparison, the binding of taxol to DNA
 .occurs at a much lower concentration 2 nM to yield
complex in which taxol binds DNA in a monomeric
form rather than as an aggregate.
REES data has provided further insight into taxol
aggregation behaviour and its DNA binding property.
Most fluorophores do not display any REES in free
form because the time scale for solvent reorientation
y12 w xin such conditions is of the order of 10 s 27,28 .
 .Free taxol exhibits a REES 12 nm which may be a
consequence of the ‘hydrophobic collapse’ assisted
formation of ‘taxol aggregates’. The relationship be-
tween the magnitude of REES and the fluorophore’s
binding to its substrate has earlier been shown in case
 .of 2-p-toulidinyl naphthalene sulfonate TNS , an
extensively used fluorescent probe to study protein
w xstructure 28 . In solution, free TNS does not show
any REES, whereas when bound to apomyoglobin it
exhibits a 11.5 nm REES. In light of these results, a
40 nm REES of taxol emission is a convincing
indicator of its strong binding to DNA.
In CD, strong Cotton effects from taxol have been
shown to be both solvent and concentration depen-
w xdent 15 . A correlation of detailed NMR and CD
studies in both organic solvents and water have indi-
cated that the positions and the intensity of the CD
bands are highly sensitive to the polarity and the
aggregation state of taxol. These studies have also
provided a molecular basis for the origin of these
bands: the 298-nm band arises from the p–p )
transition of the aromatic rings of the side chain, the
shoulder at 264 nm due to the C2-O-benzoyl group
and the 232-nm band corresponds to n-p ) transition
involving the keto C5O group at C9 and the amide
carbonyl at C13. A shift in the 232-nm band towards
longer wavelength is interpreted to indicate the ag-
gregation of the drug and a shift of the 295-nm
negative band an indication of localization of taxol in
a nonpolar environment, arising from the C2X–C3X
bond rotation in the C13 side chain.
The binding of taxol to DNA led to a shifting of
the positive CD band at 232 nm to shorter wave-
 .lengths 5 nm accompanied by an increase in inten-
 .sity Fig. 6 . On the other hand, the negative band in
the 285–295 nm region showed a change in intensity
without any shift. These results strongly suggest that
taxol goes from an aggregated form while in solu-
.tion to a non aggregated form due to binding with
DNA. In the DNA bound form, taxol would be
unable to form self aggregates. Further, the C13 side
chain, projecting away from DNA is unaffected by
binding as shown by the retention of the 285-nm
band position. The slight positive increase in intensity
of this band is however, similar to that observed in
dilute, unaggregated solutions of taxol. This observa-
tion is consistent with the results from fluorescence
quenching and REES experiments.
Under similar conditions of ionic strength and pH,
intercalators like ethidium bromide and 9-aminoacri-
dine show association constants in the range of 105
y1 w xM 29 and the minor groove binding drugs such as
netropsin, distamycin and HOECHST 33258 have
higher association constants, in the range of 107 My1
w x  7 y1.30 . The computed K of taxol 1.08=10 Ma
points it to be a groove binder.
It was recently demonstrated that some DNA bind-
ing drugs inhibit DNA amplification by PCR and this
concept was employed to assess the sequence selec-
w xtivity of DNA binding drugs 31 . Earlier studies have
elucidated the effect of mithramycin on transcription
w x32 and netropsin on enhancement of PolII termina-
w xtion 33 . It would therefore be interesting to ponder
on the biological significance of present observations
that taxol binding to DNA inhibits in vitro, template
directed DNA primer extension. In view of the fact
that DNA synthesis in vitro could be inhibited by
 .taxol at concentration 2 nM much lower than that
 .affecting tubulin polymerisation 50 nM , it is tempt-
ing to suggest that, low amounts taxol permeating
into cells may inhibit DNA replication and possibly
translation, leading to cell death. Further experiments
are needed to explore such ideas.
5. Conclusions
In summary, this paper demonstrates the hitherto
unknown interaction of taxol and some of its ana-
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logues directly with DNA. The association occurs in
the DNA groove through the eight-membered taxane
core ring, with the three phenyl rings pointing away
and is similar to that proposed for taxol–tubulin
interaction. In light of such evidence for DNA–taxol
interactions it remains to be seen whether DNA may
be an additional site of action for taxol. Very low
concentrations of the drug reaching normal cells may
cause damage by interacting with DNA. Unlike the
earlier spectroscopic studies most of the present ob-
servations are in aqueous medium under physio-
logical conditions. The observed significant binding
 7 y1.of taxol to DNA ca. 10 M has possible clinical
implications even at low dose treatment, thus assum-
ing biological importance in the context of the side
effects and pharmacokinetics of the drug.
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